Monday, May 23, 2022 4:08:10 AM
OTC Markets Group may review a Caveat Emptor designation upon request by the company and may determine, in its sole discretion, to remove the designation. The Caveat Emptor designation is typically not removed within the first 30 days of designation. To be eligible for a review, a company must meet the qualifications for Pink Current Information, have a verified the information on its company profile on www.otcmarkets.com, and demonstrate to OTC Markets Group that there is no longer a public interest concern. OTC Markets Group requires Caveat Emptor securities that are not eligible for proprietary broker quotations (Unsolicited Only) to have a Form 211 cleared by FINRA in order to be eligible for a review (e.g. securities previously halted or trade suspended by a regulatory authority).
https://www.otcmarkets.com/learn/caveat-emptor
Please do not take my post as a buy or sell recommendation, please do your own DD.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM